Healthpeak-Backed Janus Living Raises $840M in Upsized IPO
Event summary
- Janus Living priced its upsized IPO at $20.00 per share, raising $840M from 42M shares.
- Underwriters have a 30-day option to purchase an additional 6.3M shares.
- Healthpeak will retain ~83.6% voting interest post-IPO (81.6% if option exercised).
- Shares begin trading on NYSE under ticker 'JAN' on March 20, 2026.
The big picture
This IPO marks Healthpeak's strategic pivot toward a pure-play senior housing REIT structure, capitalizing on demand for high-quality senior living communities. The $840M raise positions Janus Living to compete aggressively in a fragmented sector, though Healthpeak's dominant voting stake raises questions about true separation between the entities. The deal underscores the ongoing consolidation trend in healthcare real estate.
What we're watching
- Ownership Dynamics
- How Healthpeak's 83.6% voting stake will influence Janus Living's operational independence.
- Capital Deployment
- Whether Janus Living can execute on acquisition targets with the $840M proceeds.
- Market Reception
- The pace at which Janus Living's shares trade post-IPO relative to $20 offering price.
Related topics